Sujuan Ba, Ph.D.
Dr. Sujuan Ba joined the National Foundation for Cancer Research ("NFCR") as Science Director in 1999 and was elevated to Chief Operating Officer and Chief Scientific Officer in 2002. Dr. Ba currently oversees NFCR's strategic operations, fundraising & partnership development, and oversees cancer research programs at universities and research hospitals worldwide.
Since joining the NFCR, Dr. Ba, recognizing a cure for cancer could only be achieved through collaboration, organized the establishment of a powerful international network of research centers in addition to NFCR's traditional laboratory research support model. These research centers have been established to focus on clearly identifiable and critical aspects of cancer research, uniting scientists from a broad array of backgrounds and allowing them more freedom to explore innovative ideas. This platform has been credited in some cases of saving three to five years in the cancer drug discovery process. Dr. Ba then co-founded Inhibox Ltd., based in Oxford, England with the University of Oxford to explore the biological efficacies of molecules for novel cancer therapies.
Prior to joining NFCR in 1999, Dr. Ba was Director of Chiral Chemistry and Fine Chemical Consulting Services at Technology Catalysts International (TCI) where she directed market research, business evaluation, and competitive intelligence for an international clientele of fine chemical and pharmaceutical companies.
From 1991-1997, Dr. Ba was the Principal Research Chemist and then Project Manager of Technology Development and Research Planning at Arco Chemical Company. She was responsible for evaluating technology opportunities for ARCO's core products and establishing academic and corporate research collaboration programs.
Dr. Ba has served as business development consultant for many biotech and fine chemical companies over the years. Currently, Dr. Ba is a member of the board for AFID Therapeutics , the Scientific Advisory Board of United Devices, SoftLogic Solution, and United Med-Health International Group. She is a steering committee member for Chemistry in Cancer Research of American Association for Cancer Research and also a member of the Editorial Advisory Board for The American Breast Cancer Guide. Dr. Ba serves as a visiting professor at the College of Pharmacy of Tianjin University and the Institute of Medicinal Biotechnology of the Chinese Academy of Medical Sciences.
Dr. Ba was born in Kaifeng, Henan Province of China. She received her B.S. in Radiochemistry from Peking University; and her Ph.D. in Chemistry from the University of Pennsylvania. Dr. Ba is frequently quoted as an expert in the biomedical and fine chemical industries and has appeared on CNN, ABC News, PBS, and many other television programs to discuss new discoveries and technologies in cancer research.
« return